How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
Synthetic glucocorticoids serve as co-medication against solid malignant tumors. However, glucocorticoid receptor activation may promote unsolicited cancer resistance to chemotherapy. The Kang team elucidated a glucocorticoid receptor-centred chemotherapy-resistance mechanism to cisplatin and charac...
Guardado en:
Autores principales: | Dorien Clarisse, Karolien De Bosscher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/654e0ecf4dbe442bb12413eb1bce88ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
por: Chaoyun Pan, et al.
Publicado: (2021) -
Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor
por: Ioanna Petta, et al.
Publicado: (2017) -
Compound A, a selective glucocorticoid receptor modulator, enhances heat shock protein Hsp70 gene promoter activation.
por: Ilse M Beck, et al.
Publicado: (2013) -
Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Sreenivasa R. Chinni
Publicado: (2021) -
Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
por: Yingyan Yu
Publicado: (2021)